![Efficacy and tolerance of frontline bevacizumab-based chemotherapy for advanced non-small cell lung cancer patients: a multicenter, phase IV study of the Hellenic Oncology Research Group (HORG)]()
Efficacy and tolerance of frontline bevacizumab-based chemotherapy for advanced non-small cell lung cancer patients: a multicenter, phase IV study of the Hellenic Oncology Research Group (HORG)Matikas, A.; Kentepozidis, Ν.; Ardavanis, A.; Vaslamatzis, M.; Polyzos, A.; Emmanouilides, Ch.; Katsaounis, P.; Koinis, F.; Xynogalos, S.; Christopoulou, A.; Ziras, N.; Tegos, Th.; Prinarakis, E.; Hatzidaki, D.; Georgoulias, V.; Kotsakis, A. · Cancer Chemotherapy and Pharmacology · 2016